Steffen Deichmann

University of Lübeck, University Hospital Schleswig-Holstein

Papers

Total Citations

H-Index

About

Steffen Deichmann is a pioneering surgeon advancing the frontiers of minimally invasive and robotic-assisted oncologic surgery. His primary research focuses on the application of novel robotic platforms and minimally invasive techniques for complex upper gastrointestinal and pancreatic malignancies. Deichmann’s major contributions include comprehensive evaluations of minimally invasive pancreatic surgery, where his 2023 literature review (7 citations) critically assessed the evidence for laparoscopic and robotic approaches in distal pancreatectomy and pancreatoduodenectomy for pancreatic cancer, helping to clarify their safety and oncologic efficacy compared to open surgery. He is also a leading voice in the clinical implementation of next-generation robotic systems. In a landmark 2025 study (2 citations), Deichmann provided the first description of a transhiatal esophagectomy for AEG Siewert type 2 tumors using the novel Hugo™ robotic-assisted surgery system, demonstrating the platform’s modularity and open-console design for complex oncologic resections. His work is instrumental in shaping the future of robotic surgery, offering tangible evidence that these advanced technologies can expand the boundaries of what is possible in minimally invasive cancer treatment.